Loading…
Simple
Expanded
Grid
By Venue
TRACK — Breakthroughs in Guiding Early-Stage Research [clear filter]
Tuesday, October 2
 

11:40am EDT

Introduction From Breakthroughs in Guiding Early-Stage Research Track Chair
Speakers
avatar for Natalia Borinshteyn

Natalia Borinshteyn

former Vice President, Medical Affairs, HCV Launch Team, ABBVIE

Tuesday October 2, 2018 11:40am - 11:50am EDT
Hilton Boston Logan Airport
  TRACK — Breakthroughs in Guiding Early-Stage Research

11:50am EDT

Improve Orphan Drug Strategy so Your Company Can Grow up With Your Patients
• Review opportunities for biopharma companies to continue listening to patients long after a drug has launched, particularly as pediatric patients become adults and their needs evolve
• Turn patient and physician insights into new formulations, new doses, and new storage options
• Go beyond scientific innovation to address changing patient needs through ambassador and other programs
Moderators
LN

Lauren Neighbours

Head, Regulatory Affairs, PSI-CRO

Speakers
LL

Leslie Leahy

Vice President, Head of Medical Sciences, OVID THERAPEUTICS
avatar for Holly May

Holly May

Vice President, Sales and Marketing, SOBI

Tuesday October 2, 2018 11:50am - 12:30pm EDT
Hilton Boston Logan Airport
  TRACK — Breakthroughs in Guiding Early-Stage Research

12:30pm EDT

Determine “Best-in-Breed” Status to Realize Advances in Immuno-Oncology
  • See farther and discern signals in a very crowded, poorly understood market
  • Tell a convincing story of clinical relevance out of the hundreds of immuno-oncology targets
  • Win over investors about recruitment going well
Moderators
avatar for Andrew Allen

Andrew Allen

CEO, GRITSTONE ONCOLOGY

Speakers
avatar for Lawrence Bloch

Lawrence Bloch

President, INFINITY PHARMACEUTICALS
avatar for Sridhar Ramaswamy

Sridhar Ramaswamy

Vice President, Translational R&D, TESARO

Tuesday October 2, 2018 12:30pm - 1:10pm EDT
Hilton Boston Logan Airport
  TRACK — Breakthroughs in Guiding Early-Stage Research

2:10pm EDT

Develop Combination Therapies for Immuno-Oncology
  • Analyze where the field is going beyond the checkpoint blockade
  • Focus on challenges and opportunities for antibody therapeutics, bispecific and multivalent approaches in I-O
  • Optimize combination therapy regimens


Moderators
avatar for Amirah Al Idrus

Amirah Al Idrus

Editor, FIERCEBIOTECH

Speakers
avatar for Sean McCarthy

Sean McCarthy

CEO, CYTOMX
avatar for Thomas Schuetz

Thomas Schuetz

CEO, COMPASS THERAPEUTICS

Tuesday October 2, 2018 2:10pm - 2:50pm EDT
Hilton Boston Logan Airport
  TRACK — Breakthroughs in Guiding Early-Stage Research

2:50pm EDT

Establish the Academic Partnerships Necessary for Success in Early Clinical Stages While Improving Trial Transparency
  • Navigate cultural divides between biotech and academia 
  • Work to make all partners equally aware of the need to protect and build IP 
  • Cut through the hype commonly found in early research
  • Discuss the pros and cons of an industrywide, open-data approach 
  • Envision the technical challenges of collating, storing, and sharing large volumes 

Moderators
CH

Conor Hale

Associate Editor, FIERCEBIOTECH

Speakers
avatar for Jim Doherty

Jim Doherty

Chief Research Officer, SAGE THERAPEUTICS
avatar for Lisa McKerracher

Lisa McKerracher

CEO, BIOAXONE BIOSCIENCES
avatar for Joseph Menetski

Joseph Menetski

Associate Vice President, FNIH BIOMARKERS CONSORTIUM
avatar for Chandra Ramanathan

Chandra Ramanathan

Vice President and Head, East Coast Innovation Center, BAYER

Tuesday October 2, 2018 2:50pm - 3:30pm EDT
Hilton Boston Logan Airport
  TRACK — Breakthroughs in Guiding Early-Stage Research

3:30pm EDT

Select Ideal Animal Models for Early Research to Improve the Preclinical-to-Clinical Transition
  • Track a rapidly evolving field to find the most appropriate animal models 
  • Anticipate when data expectations will shift completely out of animals and into the clinic
  • Balance how much you spend on preclinical research with how hard you try to accelerate development to clinical stages


Moderators
avatar for Adrienne Takacs

Adrienne Takacs

former COO, Senior Director, R&D Operations, ELI LILLY

Speakers
avatar for Jean-Philippe Combal

Jean-Philippe Combal

CEO, VIVET THERAPEUTICS
avatar for Carol Robertson-Plouch

Carol Robertson-Plouch

Founder, CONVERGENCE BIOSCIENCE

Tuesday October 2, 2018 3:30pm - 4:10pm EDT
Hilton Boston Logan Airport
  TRACK — Breakthroughs in Guiding Early-Stage Research

4:40pm EDT

Leverage 3DP Technologies to Accelerate Time to Market
  • Use novel dosage forms to minimize R&D iterations of dosing frequency and dose size 
  • Provide real-time formulation support for adaptive clinical trials
  • Accommodate fragile molecules and particles to speed the translation to final product scale 


Speakers
avatar for Timothy Tracy

Timothy Tracy

CEO, APRECIA PHARMACEUTICALS

Tuesday October 2, 2018 4:40pm - 5:20pm EDT
Hilton Boston Logan Airport
  TRACK — Breakthroughs in Guiding Early-Stage Research
 
Wednesday, October 3
 

8:50am EDT

Introduction From Track Chair
Speakers
avatar for Doug Fambrough

Doug Fambrough

CEO, DICERNA PHARMACEUTICALS

Wednesday October 3, 2018 8:50am - 9:00am EDT
Hilton Boston Logan Airport
  TRACK — Breakthroughs in Guiding Early-Stage Research

9:00am EDT

Find New Drivers for Success After Prior Research Failures in CNS, Oncology, Rare Disease, and Gene Therapy
  • Learn from past over-reliance on soft or subjective endpoints and a shallow dynamic range 
  • Prioritize a clear mechanism, strong transitional biomarkers, and strong responders 
  • Get early signals around the PKPD relationship in phase I, prior to efficacy data 
Moderators
avatar for David Shoemaker

David Shoemaker

Senior Vice President, R&D, RHO

Speakers
avatar for Neal Farber

Neal Farber

CEO, NEUROHEALING PHARMACEUTICALS
avatar for Agustin Melian

Agustin Melian

Senior Vice President, Global Medical Sciences, ALEXION PHARMACEUTICALS

Wednesday October 3, 2018 9:00am - 9:40am EDT
Hilton Boston Logan Airport
  TRACK — Breakthroughs in Guiding Early-Stage Research

9:40am EDT

Gene Editing: The Next Wave of Personalized Medicine
  •  Outline challenges of personalized medicine in hematological malignancies
  • Explore combination or sequencing of cell-based and molecular-directed therapy
  • Use gene editing alliances to tackle intrinsic complexity


Speakers
avatar for Stefan Scherer

Stefan Scherer

Senior Vice President, Clinical Development, Deputy CMO, CELLECTIS

Wednesday October 3, 2018 9:40am - 10:20am EDT
Hilton Boston Logan Airport
  TRACK — Breakthroughs in Guiding Early-Stage Research

10:50am EDT

A Dilemma in Immuno-Oncology: Unreliable Mice or Unaffordable People?
  • Explore whether you can escape inefficiencies in current drug development 
  • Quantify the time and resources being diverted towards steps that may not be helpful to the overall development
  • Shift the paradigm away from economical signaling pathways highly conserved in mouse models
  • Conceptualize cheaper models that can kill off programs, molecules, and combinations that don’t work, before relying on clinical tests
Speakers
avatar for Samuel Blackman

Samuel Blackman

Senior Vice President, Head of Clinical Development, SILVERBACK THERAPEUTICS

Wednesday October 3, 2018 10:50am - 11:30am EDT
Hilton Boston Logan Airport
  TRACK — Breakthroughs in Guiding Early-Stage Research

11:30am EDT

Fill Your Early-Stage Pipeline With Creative Approaches to Search, Evaluation, and Partnership
  • Tailor your business model to outperform with emerging opportunities
  • Create business development and collaboration models specific to the early stages of R&D
  • Accelerate assets from the “eureka” moment to first-in-human trials

Moderators
avatar for Adrienne Takacs

Adrienne Takacs

former COO, Senior Director, R&D Operations, ELI LILLY

Speakers
avatar for Jake Reder

Jake Reder

CEO, CELDARA MEDICAL

Wednesday October 3, 2018 11:30am - 12:10pm EDT
Hilton Boston Logan Airport
  TRACK — Breakthroughs in Guiding Early-Stage Research

12:10pm EDT

Partnership and Pipeline Strategies for Digital Therapeutics
  • Improve the prescription and reimbursement rates 
  • Clarify the logistics from the patient and pharmacy side
  • Address each partner’s concerns about reimbursement, market potential, and health outcomes
  • Build the mind-shift that the market needs from a scientific, legal, IP, regulatory, technological, and organizational perspective
  • Launch and maintain digital drugs while maintaining patient privacy
Moderators
avatar for David Benshoof Klein

David Benshoof Klein

CEO, CLICK THERAPEUTICS

Speakers
avatar for Ruchita Sinha

Ruchita Sinha

Senior Director of Investments, SANOFI VENTURES
avatar for Jeremy Sohn

Jeremy Sohn

Vice President, Global Head of Digital Business Development & Licensing, NOVARTIS
avatar for Alex Waldron

Alex Waldron

Chief Commercial Officer, PEAR THERAPEUTICS

Wednesday October 3, 2018 12:10pm - 12:50pm EDT
Hilton Boston Logan Airport
  TRACK — Breakthroughs in Guiding Early-Stage Research

1:50pm EDT

Explore New Modalities in Immuno-Oncology
  • Analyze latest advances in CAR-T and checkpoint inhibitors
  • Delve into breakthrough technology of pyroptosis
  • Weigh pros and cons of new technologies

Speakers
avatar for David Sherris

David Sherris

CEO, GENADAM THERAPEUTICS

Wednesday October 3, 2018 1:50pm - 2:30pm EDT
Hilton Boston Logan Airport
  TRACK — Breakthroughs in Guiding Early-Stage Research

2:30pm EDT

Strengthen Immuno-Oncology Portfolios Through Relevant Preclinical Models of Disease
  • Gain access to patient-derived xenoblast models as translational tools 
  • Develop faithful models that represent tumor biology and the intersection of the immune microenvironment and system
  • Reach the next step in providing humanized mouse immune systems
Moderators
avatar for David Sherris

David Sherris

CEO, GENADAM THERAPEUTICS

Speakers
avatar for Ronald Herbst

Ronald Herbst

Vice President, R&D, Head of Oncology Research, MEDIMMUNE
PS

Peter Smith

CSO, H3 BIOMEDICINE

Wednesday October 3, 2018 2:30pm - 3:10pm EDT
Hilton Boston Logan Airport
  TRACK — Breakthroughs in Guiding Early-Stage Research
 
Filter sessions
Apply filters to sessions.
Monday, October 1
Tuesday, October 2
Wednesday, October 3
Hilton Boston Logan Airport
TBA
  • General Session
  • Networking
  • Sponsored Session
  • TRACK — Breakthroughs in Guiding Early-Stage Research
  • TRACK — Strategic Deal-Making & Partnering
  • Workshop